Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. by Francesca Catto (21253435)

“…Additionally, the plots on the right side display the average plaque count across the cohorts. …”

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Side effect. by My Tra Thi Nguyen (22120541)

“…QoL also significantly improved, with CU-Q2oL scores dropping from 44.9 at baseline to 25.3 at week 8. …”

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Schematic representation of the study protocol. by Neng Pan (5262032)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

Subjects:

Comparison within groups. by Neng Pan (5262032)

Subjects:

Comparison before and after the experiment in each group. by Neng Pan (5262032)

Subjects:

Data ste. by Neng Pan (5262032)

Subjects:

Comparison of data after the experiment. by Neng Pan (5262032)

Subjects:

Correlation diagram of each parameter in each group. by Neng Pan (5262032)

Subjects:

Recruitment process. by Neng Pan (5262032)

Subjects:

Comparison of post-experimental outcome measures. by Neng Pan (5262032)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”